颈前部皮神经构筑研究

目的　为研究皮肤疾病和损伤提供皮神经构筑资料。方法　用S 10 0蛋白免疫组化染色法研究正常成人颈前部胸锁乳突肌前、后缘皮肤各层内皮神经的数量、分布及构筑特点。结果　 ( 1)皮肤乳头层内皮神经的小分支多分布在皮突下和乳头内血管丛附近。 ( 2 )真皮网状层内神经多位于小血管附近和汗腺、皮脂腺以及毛囊周围 ,神经分支呈串珠状或波纹形。 ( 3 )皮下组织内神经干和神经网同时存在。结论　皮肤内感觉神经树的分布及构筑特点与血管树相似。     

贲门失驰缓症介入治疗的疗效评价

目的：评价贲门失弛缓症球囊扩张介入治疗的疗效。方法：对20例贲门失驰缓症患者行球囊扩张术。结果：20例患者共进行了31次球囊扩张，人均1．5次（其中12例扩张1次，5例扩张2次，3例扩张3次）。术后患者吞咽困难明显缓解，主要并发症为疼痛和返流。术后随访无症状期为3－13个月。结论：球囊扩张术是治疗门失弛缓症的有效方法。     

Promoting effect of the Chinese medicinal herb, wikstroemia chamaedaphne and tung oil extracts on carcinoma of the uterine cervix induced by HSV-2 or methylcholanthrene (MCA) in mice

The promoting effect of the Chinese medicinal herb, Wikstroemia chamaedaphne and Tung oil extracts (WC and HHPA) on carcinoma of uterine cervix induced by HSV-2 or MCA in mice was studied. The results showed that WC and HHPA extracts were not carcinogenic themselves. After carcinogen HSV-2 and MCA treatment, WC and HHPA were added separately. The inducing rates by HSV-2 increased from 7.4% to 21.1% and 26.3%, those by MCA increased from 56.5% to 82.8% and 84.4%. There was a significant difference between the combined groups and groups with HSV-2 or MCA only. The experimental results suggest that these two kinds of extracts play a promoting effect on carcinogenesis. The relation between the carcinogenesis of uterine cervix or nasopharynx and WC or HHPA extracts is discussed.     

浅谈分娩镇痛及其护理

目的研究理想的分娩镇痛方法及护理.方法根据疼痛的情况,在设定的范围的内持续追加麻醉药,以阻断T10～12和S2～4节段的神经传导.结果理想的理想分娩阵痛能减免产妇分娩疼痛.结论阵痛分娩可消除产妇精神紧张、恐惧、疲惫及缺乏自信和不良刺激等因素.     

Analgesic effect of intrathecal fluorocitrate on neuropathic pain in rats

Objective To investigate the analgesiac effect of intrathecal （IT） fluorocitrate （FC） （ a selective astrocyte metabolic inhibitor） on neuropathic pain induced by chronic constrictive injury （CCI） to sciatic nerve. Methods Thirty- two adult male SD rats weighing 220-280 g were randomly divided into 4 groups （ n = 8each） ： group A sham operation＋ （IT） vehicle; group B sham operation ＋ （IT） FC;group C CCI＋ （IT） vehicle and group D CCI＋ （IT） FC.     

大肠杆菌内毒素所致肺血管收缩部位及山莨菪碱的作用

将动、静脉阻断法用于恒速灌流的在体山羊左肺,使其总压力降区分为动脉端、静脉端及中间段三部分。大肠杆菌内毒素主要升高肺静脉端压力降及肺毛细血管压;山莨菪碱可显著缓解内毒素所致的改变,但对正常肺血管各段压力降无明显影响。5-羟色胺主要升高肺动脉端压力降,对肺静脉端及毛细血管压无明显影响。去甲肾上腺素及组胺主要升高肺静脉端压力降及肺毛细血管压,但对肺动脉端无明显影响。去甲肾上腺素和组胺可能介导内毒素性肺动脉高压。     

中西医治疗宫颈糜烂的临床研究

目的:探讨中西医结合治疗宫颈糜烂的疗效。方法:以三黄洗剂加用龙血竭胶囊外用,并配合西药消炎治疗宫颈糜烂40例。结果:治愈35例,治愈率87.5%;好转5例,好转率12.5%。结论:中西医结合治疗宫颈糜烂具有良好的疗效。     

Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.

Recent studies have suggested that aldosterone plays a role in the pathogenesis of renal injury. In this study, we investigated whether local angiotensin II (Ang II) activity contributes to the progression of renal injury in aldosterone/salt-induced hypertensive rats. Uninephrectomized rats were treated with 1% NaCl in a drinking solution and one of the following combinations for 6 weeks: vehicle (2% ethanol, s.c.; n=9), aldosterone (0.75 mug/h, s.c.; n=8), aldosterone+Ang II type 1 receptor blocker olmesartan (10 mg/kg/day, p.o.; n=8), or aldosterone+olmesartan (100 mg/kg/day, p.o.; n=9). Aldosterone/salt-treated hypertensive rats exhibited severe proteinuria and renal injury characterized by glomerular sclerosis and tubulointerstitial fibrosis. Aldosterone/salt-induced renal injury was associated with augmented expression of angiotensin converting enzyme and Ang II levels in the renal cortex and medullary tissues. Renal cortical and medullary mRNA expression of transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) as well as the collagen contents were increased in aldosterone/salt-treated hypertensive rats. Treatment with olmesartan (10 or 100 mg/kg/day) had no effect on blood pressure but attenuated proteinuria in a dose-dependent manner. Olmesartan at 10 mg/kg/day tended to decrease renal cortical and medullary Ang II levels, TGF-beta and CTGF expression, and collagen contents; however, these changes were not significant. On the other hand, an ultrahigh dose of olmesartan (100 mg/kg/day) significantly decreased these values and ameliorated renal injury. These data suggest that augmented local Ang II activity contributes, at least partially, to the progression of aldosterone/salt-dependent renal injury.